Extensive bone marrow necrosis and symptomatic hypercalcemia in B cell blastic transformation of chronic myeloid leukemia: Report of a case and review of the literature

Acta Haematologica

Volumn 118, Issue 2, 2007, Pages 111-116

  Noguchi, Masaaki ^a   Oshimi, Kazuo ^b  

^a JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone marrow necrosis; Chronic myeloid leukemia; Hypercalcemia; Multiple osteolysis; Prostaglandin E2; Transforming growth factor

Indexed keywords

BCR ABL PROTEIN; BISPHOSPHONIC ACID DERIVATIVE; ELCATONIN; PREDNISOLONE; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR; VINCRISTINE;

AGED; ANAMNESIS; ARTICLE; AUTOPSY; B LYMPHOCYTE; BLAST TRANSFORMATION; BONE MARROW NECROSIS; CALCIUM BLOOD LEVEL; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; COMA; COMBINATION CHEMOTHERAPY; HUMAN; HYPERCALCEMIA; LEUKOCYTE COUNT; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; PRIORITY JOURNAL; THROMBOCYTE COUNT;

BLAST CRISIS; BONE MARROW; DINOPROSTONE; DISSEMINATED INTRAVASCULAR COAGULATION; FATAL OUTCOME; HUMANS; HYPERCALCEMIA; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; NECROSIS; OSTEOLYSIS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548700871     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106100     Document Type: Article

References (47)

1. Wade L, Stevenson L: Necrosis of the bone marrow with fat embolism in sickle cell anemia. Am J Pathol 1941;17:47-59.
2. Jamssens AM, Offner FC, Van Hove WZ: Bone marrow necrosis. Cancer 2000;88:1769-1780.
3. Seymour JF, Gagel RF: Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. Blood 1993;82:1383-1394.
4. Macheta AT, Cinkotai KI, Love EM, Geary CG, Liu Yin JA: Bone marrow necrosis complicating chronic myeloid leukaemia. Clin Lab Haematol 1991;13:163-167.
5. Bain B: Extensive bone marrow infarction followed by myelofibrosis in a patient with Ph' positive chronic granulocytic leukaemia. J Clin Pathol 1980;33:449-453.
6. Kendra JR, Pickens S, Singh K: Bone marrow necrosis at transformation of chronic granulocytic leukaemia treated with interferon. J Clin Pathol 1992;45:830-831.
7. Lee CH, Morris TCM: Bone marrow necrosis and extramedullary myeloid tumor necrosis in aggressive chronic myeloid leukaemia. Pathology 1979;11:551-556.
8. Vesterby A, Jensen M: Aseptic bone/bone marrow necrosis in leukaemia. Scand J Haematol 1985;35:354-357.
9. Brown CH: Bone marrow necrosis: a study of seventy cases. Hopkins Med J 1972;171:189-203.
10. Dokal IS, Amos A, Bashey A, Goldman JM: Recurrent bone marrow necrosis and extramedullary myeloid deposits in Philadelphia-negative chronic myeloid leukemia. Hematologica 1988;73:513-515.
11. Chim CS, Ma SK, Lam CK: Bone marrow necrosis masquerading as interferon toxicity in chronic myeloid leukemia. Leuk Lymphoma 1999;33:385-388.
12. Scudla V, Dusek J, Macak J, Zivna J, Myslivecek M, Indrak K: Bone marrow necrosis in malignant disease: a report on seven intravitally recognized cases. Neoplasma 1989;35:603-610.
13. Scudla V, Dusek J, Macak J, Myslivecek M, Bacovsky J, Indrak K: Bone marrow necrosis: a report on five intravitally recognized cases and a brief review of the literature. Acta Univ Palacki Olomuc Fac Med 1987;117:195-210.
14. Rose MS: Apparent necrosis of bone marrow in a patient with disseminated intravascular coagulation, post partum. Lancet 1973;ii:730-731.
15. Knupp C, Pekala PH, Cornelius P: Extensive bone marrow necrosis in patients with cancer and tumor necrosis factor activity in plasma. Am J Hematol 1988;29:215-221.
16. Quitt M, Kelner J, Sova J, Froom P, Aghai E: Accelerated phase of chronic myeloid leukemia presenting with hypercalcemia and a mediastinal mass. Acta Haematol 1998;99:231-233.
17. Tricot G, Boogaerts MA, Orshoven AB, Criel A, Hoof AV, Berghe HVD: Hypercalcemia and diffuse osteolytic lesions in the acute phase of chronic myelogenous leukemia: a possible relation between lymphoid transformation and hypercalcemia. Cancer 1983;52:841-845.
18. Walter RM, Greenberg BR: Hypercalcemia in the accelerated phase of chronic myelogenous leukemia. Cancer 1980;46:1174-1178.
19. Nadal E, Cervantes F, Rosinol L, Talarn C, Montserrat E: Hypercalcemia as the presenting feature of T-cell lymphoid blast crisis of Ph-positive chronic myeloid leukemia. Leuk Lymphoma 2001;41:203-206.
20. Murata T, Motomura S, Hirano H, Kanamori H, Miyashita H, Ogawa K, Ookubo T: Hypercalcemia associated with blast crisis of chronic myeloid leukemia. Jpn J Clin Hematol 1990;31:177-182.
21. Attar E, Prokocimer M, Januszewicz E, Theodor E: Hypercalcemia complicating myelomonoblastic transformation of chronic myeloid leukemia. Acta Haematol 1988;79:211-212.
22. Joyner MV, Dujardin P, Cassuto JP, Audoly P: Hypercalcemia as complication of accelerated chronic granulocytic leukemia. Br Med J 1977;ii:1060.
23. Sasaki Y, Takahashi T, Tsuyuoka R, Tanaka K, Ishida H, Nakao K, Shigeno C, Nakamura K, Kozuki M, Okada H, Katakami H: Hypercalcemia mediated by parathyroid hormone-related protein in chronic myeloid leukemia. Am J Hematol 1994;47:251-252.
24. Kornberg A, Amir G, Leizerowitz R, Rachmilewitz EA: Hypercalcemia complicating a megakaryoblastic crisis of chronic myelocytic leukemia. Isr J Med Sci 1988;24:247-249.
25. Ballard HS, Marcus AJ: Hypercalcemia in chronic myelogenous leukemia. N Engl J Med 1970;282:663-665.
26. Licht A, Many N, Rachmilewitz EA: Myelofibrosis, osteolytic bone lesions and hypercalcemia in chronic myeloid leukemia. Acta Haematol 1973;49:182-189.
27. Hasselbalch H, Birgens HS, Geisler C, Hansen NE: Hypercalcemia in the accelerated phase of chronic myelogenous leukaemia: no relationship to the phenotype of the blast cells. Scand J Haematol 1985;35:333-338.
28. Beukes CA, Vorster BJ, Heyns ADP: Metamorphosis of chronic granulocytic leukaemia, lytic bone lesion and hypercalcaemia: a case report. S Afr Med J 1980;58:214-216.
29. Rasheed Z, Looker RF, Grant KB: Hypercalcemia and its prognostic implications in chronic myelogenous leukemia - a case report. J Iowa Med Soc 1975;10:423-425.
30. Licht A, Many N, Rachmilewitz EA: Myelofibrosis, osteolytic bone lesions and hypercalcemia in chronic myeloid leukemia. Acta Haematol 1973;49:182-189.
31. Kubota K, Yanagisawa T, Kurabayashi H, Ono K, Shirakura T, Nagashima K, Yatabe H, Nakazato Y: Hypercalcemia associated with osteolytic lesions in the extramedullary blastic crisis of chronic myelogenous leukemia: report of a case. Blut 1989;59:458-459.
32. Haskell CM, Devita VT, Canellos GP: Hypercalcemia in chronic granulocytic leukemia. Cancer 1970;27:872-880.
33. Collin R, Griffiths H, Polacarz SV, Lawrence AC, Watmore A: Mithramycin therapy for resistant hypercalcaemia in transformed chronic granulocytic leukaemia. Clin Lab Haematol 1989;11:156-159.
34. Steinberg D, Osofsky M, Rubin AD: Acute phase of chronic granulocytic leukemia. Onset signaled by hypercalcemia and multiple osteolytic lesions. NY J Med 1971;75:583-586.
35. Groebner DT, Mork JN, Barlow JF: Hypercalcemia in chronic myelogenous leukemia. Minn Med 1980;63:237-239.
36. McKee LC, Jr: Hypercalcemia in leukemia. South Med J 1974;67:1076-1079.
37. Molho P, Grange MJ, Gueris J, Ballet JJ, Wautier JL, Tobelem G, Caen JP: Hypercalcemia in chronic myelogenous leukemia: evidence for excessive parathyroid hormone secretion. Nouv Rev Fr Hematol 1985;27:189-192.
38. Linssen A, Wetsteyn JC: Hypercalcaemia complicating chronic granulocytic leukaemia (CGL). Neth J Med 1979;22:153-157.
39. Demers LM, Allegra JC, Harvey HA, Lipton A, Luderer JR, Mortel R, Brenner DE: Plasma prostaglandins in hypercalcemic patients with neoplastic disease. Cancer 1977;39:1559-1562.
40. Franklin RB, Tashjian AH: Intravenous infusion of prostaglandin E2 raises plasma calcium concentration in the rat. Endocrinology 1975;97:240-243.
41. Stern PH, Krieger NS, Nissenson RA, Williams RD, Winkler ME, Derynck R, Strewler GJ: Human transforming growth factor-α stimulates bone resorption in vitro. J Clin Invest 1985;76:2016-2019.
42. Tashjian AH, Voelkel EF, Lazzaro M, Singer FR, Roberts AB, Derynck R, Winkler ME, Levine L: α and β human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Sci USA 1985;82:4535-4538.
43. Amirzargar AA, Bagheri M, Ghavamzadeh A, Alimoghadam K, Khosravi F, Rezaei N, Moheydin M, Ansaripour B, Moradi B, Nikbin B: Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 2005;32:167-171.
44. Sanduja SK, Trial J, Hall ER: Prostaglandin production by human promyelocytic leukemia (HL-60) cells. Biomed Biochim 1988;47:383-393.
45. Wark JD, Taft JL, Michaelangeli VP, Veroni MC, Larkins RG: Biphasic action of prostaglandin E2 on conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 in chick renal tubules. Prostaglandins 1984;27:453-463.
46. Ishida A, Fujita N, Kitazawa R, Tsuruo T: Transforming growth factor-β induces expression of receptor activator of NF-κB ligand in vascular endothelial cells derived from bone. J Biol Chem 2002;277:26217-26224.
47. Li J, Sarosi I, Yan X, Morony S, Capparelli C, Tan H, McCabe S, Elliot R, Scully S, Van G, Kaufman S, Juan S, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ: RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 2000;97:1566-1571.